Fulcrum Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
21.89
|
|
Average Rating
|
4.22
|
|
# Strong Buys
|
3
|
|
# Buys
|
5
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.61
|
-0.51
|
0.10
|
16.39%
|
|
2022-06-30
|
-0.66
|
-0.83
|
-0.17
|
-25.76%
|
|
2022-03-31
|
-0.63
|
-0.64
|
-0.01
|
-1.59%
|
|
2021-12-31
|
-0.73
|
-0.58
|
0.15
|
20.55%
|
|
2021-09-30
|
-0.65
|
-0.57
|
0.08
|
12.31%
|
|
2021-06-30
|
-0.62
|
-0.60
|
0.02
|
3.23%
|
|
2021-03-31
|
-0.66
|
-0.54
|
0.12
|
18.18%
|
|
2020-12-31
|
-0.72
|
-0.64
|
0.08
|
11.11%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.98
|
|
2021-12-31
|
-2.29
|
|
2020-12-31
|
-2.81
|
|
2019-12-31
|
-11.20
|